PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported September 22, 2021

Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (NDC 61748-480-30), b) 60 mL bottle (NDC 61748-480-60), Rx only, Manufactured by: Hi-Tech Pharmacal Co. Inc., Amityville,NY 11701

Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.

Recall #
D-0802-2021
Affected scope
264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289
Initiated
August 13, 2021
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

Akorn, Inc. recalled Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (ND… - a moderate-severity action.

Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (ND… was recalled by Akorn, Inc. in September 22, 2021. Reason: Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical…. Check the official notice for the remedy. Verify recall #D-0802-2021 with the FDA Drug before acting.

The recall

Akorn, Inc. issued this moderate-severity FDA Drug recall-Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical….

Moderate
severity level
Class II
classification
September 22, 2021
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0802-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0802-2021) was formally reported on September 22, 2021, with the manufacturer initiating the action on August 13, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Akorn, Inc. is listed as the recalling firm, operating out of Lake Forest, IL. Federal records list the affected scope as 264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289.

The documented reason for this recall is: Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product. Distribution data in the federal record shows the product reached: USA Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,731 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 146
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289

Related Recalls

6

0 from same agency

Product description

Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (NDC 61748-480-30), b) 60 mL bottle (NDC 61748-480-60), Rx only, Manufactured by: Hi-Tech Pharmacal Co. Inc., Amityville,NY 11701

Reason for recall

Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-0802-2021
Date reported September 22, 2021
Date initiated August 13, 2021
Recalling firm Akorn, Inc.
Firm location Lake Forest, IL
Affected scope 264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289
Distribution USA Nationwide

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0802-2021) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Betamethasone Dipropionate Lotion USP (Augmented), 0.05%, packaged in a) 30 mL bottle (NDC 61748-480-30), b) 60 mL bottle (NDC 61748-480-60), Rx only, Manufactured by: Hi-Tech Pharmacal Co. Inc., Amityville,NY 11701. Recalled by Akorn, Inc.. Units affected: 264 bottles; 48 bottles lot 372286 and 216 bottles lot 372289.
Why was this product recalled?
Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 22, 2021. Severity: Moderate. Recall number: D-0802-2021.
Where was the recalled product distributed?
Distribution: USA Nationwide.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0802-2021) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →

Browse all Children & Baby Products recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported September 22, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.